Abstract
We performed genomic, epigenomic, transcriptomic, and proteomic characterizations of uterine carcinosarcomas (UCSs). Cohort samples had extensive copy-number alterations and highly recurrent somatic mutations. Frequent mutations were found in TP53, PTEN, PIK3CA, PPP2R1A, FBXW7, and KRAS, similar to endometrioid and serous uterine carcinomas. Transcriptome sequencing identified a strong epithelial-to-mesenchymal transition (EMT) gene signature in a subset of cases that was attributable to epigenetic alterations at microRNA promoters. The range of EMT scores in UCS was the largest among all tumor types studied via The Cancer Genome Atlas. UCSs shared proteomic features with gynecologic carcinomas and sarcomas with intermediate EMT features. Multiple somatic mutations and copy-number alterations in genes that are therapeutic targets were identified.
Original language | English (US) |
---|---|
Pages (from-to) | 411-423 |
Number of pages | 13 |
Journal | Cancer Cell |
Volume | 31 |
Issue number | 3 |
DOIs | |
State | Published - Mar 13 2017 |
Bibliographical note
Funding Information:We wish to thank all patients and families who contributed to this study. This work was supported by the following grants from the US NIH: U54 HG003273, U54 HG003067, U54 HG003079, U24 CA143799, U24 CA143835, U24 CA143840, U24 CA143843, U24 CA143845, U24 CA143848, U24 CA143858, U24 CA143866, U24 CA143867, U24 CA143882, U24 CA143883, U24 CA144025, and P30 CA016672. Andrew D. Cherniack and Matthew Meyerson declare research funding from Bayer AG.
Publisher Copyright:
© 2017 Elsevier Inc.
Keywords
- EMT
- TGGA
- The Cancer Genome Atlas
- UCS
- endometrial cancer
- epithelial-to-mesenchymal transition
- gynecologic cancer
- gynecologic oncology
- translational science
- uterine carcinosarcoma